If yes and its Wegovy, price the pill first at $149, then the pen at $349 after the intro months
Overall survival on the pump was 71% and 62% at 12 and 24 mo, respectively for the PC and 72% and 47% at 12 and 24 mo for the RC
Baseline factors including irritable bowel syndrome history, medication sensitivities, dietary fiber intake, and metabolic status all correlate with diarrhea severity
Regular monitoring of blood sugar levels and other vital signs is necessary to guarantee optimal outcomes during treatment
Also in September 2025, FDA established a Green List Import Alert (66-80) to help stop GLP-1 APIs that have potential quality concerns from entering the U.S
Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth